Brief: Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
07/02/2025 13:16
Feb 7 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PRESENTS POSITIVE PRELIMINARY DATA FROM
ONGOING PHASE 3 TRANSPORTNPC™ OPEN-LABEL SUB-STUDY IN PATIENTS
(< 3 YEARS OLD)
* CYCLO THERAPEUTICS - ON TRACK FOR TOPLINE DATA FROM
48-WEEK
INTERIM ANALYSIS OF 104 ENROLLED PATIENTS IN TRANSPORTNPC IN H1
2025
Source text: ID:nBw9wfPVca
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug